3H-phenothiazine | 261-87-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并硫氮卓类
• 英文名称: 3H-phenothiazine
• CAS: 261-87-0
• 化学式: C₁₂H₉NS
• 分子量: 199.276
• InChiKey: FIICCGOYRVMEPV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  37.7
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Use of lipoxygenase inhibitors for the preparations of cytoprotective pharmaceutical compostions and process for the preparation of a cytoprotective pharmaceutical composition
  申请人：Merck & Co., Inc.

  公开号：EP0155623A2

  公开（公告）日：1985-09-25

  Lipoxygenase inhibitors are used as cytoprotective active ingredient in producing cytoprotective pharmaceutical compositions. Corresponding cytoprotective pharmaceutical compositions are prepared by incorporating into a pharmaceutical composition a lipoxygenase inhibitor in a cytoprotective active amount. The prepared cytoprotective therapeutic composition may be used to treat or prevent disease states such as erosive gastritis, erosive esophagitis, inflammatory bowel disease, and induced hemorrhagic gastric erosions such as those caused by indomethacin or ethanol. The lipoxygenase inhibitors induce cytoprotection via an unspecified mechanism.

  脂氧合酶抑制剂作为细胞保护活性成分可用于生产细胞保护药物组合物。相应的细胞保护药物组合物是通过在药物组合物中加入具有细胞保护活性量的脂氧合酶抑制剂来制备的。制备的细胞保护治疗组合物可用于治疗或预防疾病状态，如糜烂性胃炎、糜烂性食管炎、炎症性肠病和诱导性出血性胃糜烂，如由吲哚美辛或乙醇引起的胃糜烂。脂氧合酶抑制剂通过不明机制诱导细胞保护。
• METHOD FOR CONVERTING N,N-DIALKYLAMIDE COMPOUND INTO ESTER COMPOUND USING COMPLEX OF FOURTH-PERIOD TRANSITION METAL AS CATALYST
  申请人：Takasago International Corporation

  公开号：EP3760607A1

  公开（公告）日：2021-01-06

  The present invention relates to a method for converting an N,N-dialkylamide compound into an ester compound using, as a catalyst, a complex of a fourth-period transition metal, the complex being obtained by reacting a precursor including the fourth-period transition metal with a nitrogen compound or phosphorus compound.

  本发明涉及一种将 N,N-二烷基酰胺化合物转化为酯类化合物的方法，该方法使用第四周期过渡金属的络合物作为催化剂，该络合物是通过将包括第四周期过渡金属的前体与氮化合物或磷化合物反应而获得的。
• Method for converting N,N-dialkylamide compound into ester compound using complex of fourth-period transition metal as catalyst
  申请人：TAKASAGO INTERNATIONAL CORPORATION

  公开号：US11377415B2

  公开（公告）日：2022-07-05

  A method for converting an N,N-dialkylamide compound into an ester compound includes using a fourth period transition metal complex as a catalyst. The fourth period transition metal complex is obtained by a reaction of a precursor having a fourth period transition metal with a nitrogen-containing compound or a phosphorus-containing compound.

  一种将 N,N-二烷基酰胺化合物转化为酯类化合物的方法包括使用第四周期过渡金属络合物作为催化剂。第四周期过渡金属络合物是通过具有第四周期过渡金属的前体与含氮化合物或含磷化合物反应得到的。
• NOVEL ORGANIC SEMICONDUCTOR COMPOUND, METHOD FOR PREPARING SAME, AND ORGANIC SEMICONDUCTOR COMPOSITION, AND ORGANIC SEMICONDUCTOR THIN FILM AND ELEMENT CONTAINING THE SAME
  申请人：Han Sung Hwan

  公开号：US20110253944A1

  公开（公告）日：2011-10-20

  The present invention relates to a novel polycyclic aromatic organic semiconductor compound having a polycyclic aromatic core, a method for preparing the same, and electronic, optical or electro-optical devices such as an organic semiconductor composition, organic semiconductor thin film, organic field effect transistor and solar cell containing the compound. The novel organic semiconductor compound according to the present invention has high crystallinity and control capability, and facilitates control of doping conditions in the manufacture of organic semiconductor element so that it can be used for diverse applications. The compound can be mass-produced at low cost and has high solubility in organic solvents so that a liquid phase process can be applied to the manufacture of semiconductor elements and the like, thus enabling the mass-production of semiconductor elements and solar cells at low cost.
• RADICALLY POLYMERIZABLE PHENOTHIAZINE MACROMONOMER FOR USE IN THE COATING OF MEDICAL DEVICES
  申请人：Fei Jiangfeng

  公开号：US20130143055A1

  公开（公告）日：2013-06-06

  The present invention is directed to phenothiazine-base macromonomer compounds and methods of making the same.